Tada, thanks for your notes. Didn’t get there this year so it was nice to get your take on the Q&A.

I hope we are never seriously discussing the marketing of Apabetalone by RVX as I really hope the entire RVX program ends up in the hands of an organization with better business management and more financial capability than we currently have. One might think the IP is getting close to a point where we could be taken out either in whole or in a good CVR by such an organization.